52% adj. EBITA growth driven by non-SE divisions '23e-'25e adj.
Under sommaren kommunicerade Learning to Sleep att bolaget avser att förvärva samtliga aktier i Bonz...
Strong AUM growth despite tough market EBIT cut for 2023-24e on persistent weak activity 2023e EV/EB...
In Q2-23, STENOCARE delivered a sales growth of 279% Y-Y, amounting to DKK 1.
Q2 dominerades av leveranser från pågående projekt.
CirChem har publicerat bolagets delårsrapport för det andra kvartalet 2023 och visar på fortsatta fr...
A rare miss on sales growth in Q2 Monopoly GO! and increased distribution excite H2 outlook for sale...
Fastighetsbolaget Eastnine aviserade en avyttring av det ryska innehavet MFG.
Stark tillväxt B2B lägre B2C Omsättningen i kvartalet uppgick till 51,0 mkr vilket motsvarar en till...
Alltainer publicerade den 23 augusti 2023 bolagets delårsrapport för sitt fjärde kvartal 2022/2023, ...
Challening market continues to affect sales Reiterates FY'23 guidance Product development in focus ...
Redeye provides a first comment on the back of Northbaze Group’s Q2 2023 report.
Redeye comments on Nanexa’s Q2 2023 report and endorses the company’s recent progress related to NEX...
Redeye comments on Beyond Frames Q2 2023 report, where net sales and profitability came in above est...
Will scale down VHP (tobacco) business by ~50% We expect initial revisions to be conservative (c.
Redeye thinks the Q2 report from Zwipe was significantly weaker than our estimates with zero revenue...
Redeye provides an initial take on SenzaGen’s H1 2023 report.
Redeye views favorably the news that Waystream has added Transtema as a partner in the Swedish marke...
